Regulatory de-risk Jordi Labs specializes in regulator-credible testing, toxicology, and E&L studies for MedTech, presenting a strong opportunity to upsell end-to-end regulatory and quality services to streamline customers’ submissions and post-market activities.

Post-market synergy Strategic partnerships with 3Aware and integration of RWE platforms signal a focus on post-market clinical follow-up and surveillance, creating a sales angle to offer PMCF and real-world evidence services to manufacturers seeking ongoing compliance and data-driven insights.

Innovation portfolio With proprietary multi-detector analytics, fern.ai Smart Authoring, and expanded E&L and contaminant investigations, there are cross-sell opportunities to customers needing advanced analytics, smart documentation, and rapid, decision-ready data for submissions.

MedTech growth As part of RQM+, Jordi Labs can leverage broader regulatory, clinical, and reimbursement expertise to pitch integrated solutions across development through post-market, appealing to MedTech companies aiming to reduce surprises and accelerate time-to-market.

Expansion readiness Recent leadership and service launches indicate a growth trajectory and capability expansion, presenting sales opportunities to engage potential customers during vendor selection RFPs aimed at comprehensive testing, risk assessment, and regulatory pathways.